$3.33
0.18[5.71%]
At close: Apr 25
$3.33
0[0.00%]
After Hours: 9:30AM EDT
Repare Therapeutics
(NASDAQ:RPTX)Latest News for Repare Therapeutics Stock (NASDAQ:RPTX)
Repare Therapeutics Stock (NASDAQ: RPTX)
Categories: All
Monday, April 15, 2024
Friday, March 08, 2024
Wednesday, February 28, 2024
Wednesday, February 21, 2024
Thursday, February 15, 2024
Wednesday, February 14, 2024
Tuesday, February 13, 2024
- Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A MonthVandana Singh - Feb 13, 2024, 8:43AM
- Repare Therapeutics shares are trading lower after Roche terminated cancer drug deal and the company regained global rights to camonsertib.Benzinga Newsdesk - Feb 13, 2024, 8:40AM
Thursday, January 04, 2024
Monday, November 20, 2023
Thursday, November 09, 2023
- These Biotech Stocks Could Double Your Money, According To AnalystsAditi Ganguly - Nov 9, 2023, 9:38AM
- Recap: Repare Therapeutics Q3 EarningsBenzinga Insights - Nov 9, 2023, 7:55AM
- Repare Therapeutics Q3 EPS $(0.45) Beats $(0.86) Estimate, Sales $2.16M Miss $6.31M EstimateBenzinga Newsdesk - Nov 9, 2023, 7:47AM
Monday, November 06, 2023
- $2.8M Bet On Repare Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively BuyingLisa Levin - Nov 6, 2023, 8:24AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Nov 6, 2023, 8:06AM
- Repare Therapeutics Shares Higher Premarket 10%+ Owner Mark Lampert Reported Purchase Of 783,709 Shares @ Avg Price Of $3.60/Share in Form 4 Filing On FridayCharles Gross - Nov 6, 2023, 5:01AM
Monday, October 16, 2023
Friday, October 13, 2023
Monday, October 09, 2023
Monday, September 25, 2023
Thursday, August 17, 2023
Thursday, August 10, 2023
Wednesday, August 09, 2023
Monday, August 07, 2023
Thursday, August 03, 2023
Friday, June 09, 2023
- Analyst Expectations for Repare Therapeutics's FutureBenzinga Insights - Jun 9, 2023, 11:01AM
- Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2023Benzinga Insights - Jun 9, 2023, 11:00AM
- Stifel Upgrades Repare Therapeutics to Buy, Raises Price Target to $16Benzinga Newsdesk - Jun 9, 2023, 10:18AM
- HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Raises Price Target to $26Benzinga Newsdesk - Jun 9, 2023, 6:26AM
Thursday, June 08, 2023
Tuesday, May 09, 2023
Thursday, April 27, 2023
- Analyst Expectations for Repare Therapeutics's FutureBenzinga Insights - Apr 27, 2023, 3:00PM
- 4 Analysts Have This to Say About Repare TherapeuticsBenzinga Insights - Apr 27, 2023, 8:01AM
- HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $25 Price TargetBenzinga Newsdesk - Apr 27, 2023, 6:26AM